国际麻醉学与复苏杂志   2016, Issue (2): 6-6
    
早期脓毒症生物分子预警的研究进展
朱飞宇, 石学银1()
1.第二军医大学长征医院麻醉科
Progress of biomolecular warnings in early stage of sepsis
 全文:
摘要:

背景 脓毒症是ICU患者的主要死亡原因,提高脓毒症预警的准确度并及时进行治疗是脓毒症早期干预的重点。失控的炎性应答可导致促炎反应/抗炎反应平衡的破坏、患者早期死亡。目前,尚无有效的生物化学技术能够提供快速可信的方法以鉴别脓毒症。 目的 归纳目前有助于早期诊断脓毒症的生物学标志物及基于多重PCR的检测方法。 内容 归纳C反应蛋白(C-reactin protein, CRP)、降钙素原(procalcitonin, PCT)、IL-6、脂多糖结合蛋白(lipopolysaccharides-binding protein, LBP)、可溶性髓系细胞触发受体-1(soluble triggering receptor expressed on myeloid cells-1, sTREM-1)、尿激酶纤溶酶原激活物(urokinase-type plasminogen activator, uPAR)、高迁移率族蛋白B1(high mobility group box 1 protein, HMGB1)、肾素?蛳血管紧张素系统(rennin angiotensin system, RAS)、基于多重PCR的病原体检测对脓毒症早期预警的作用。 趋向 尚无一种单一的生物标志物或生物分子技术可以提供准确的预警以有效地鉴别脓毒症。PCT是目前最常用于脓毒症诊断及危重程度判断的唯一实践性生物分子。未来对脓毒症早期预警的研究可更多注重联合使用多种生物学标志物。

关键词: 脓毒症; 分子预警; 进展
Abstract:

Background Sepsis contributes to major mortality in ICU patients. To improve early warning accuracy for treatment of sepsis must be the key point. Systemic inflammatory response syndrome (SIRS) and compensatory antiinflammation syndrome (CARS) are the following phases of occurring sepsis. Dysfunction of inflammatory response leads to imbalance of pro/anti?蛳 inflammatory and early death. At present, less effective biochemical technologies are helpful to increase diagnostic accuracy of sepsis. Objective This review aimed to summarize early biomarkers of sepsis and multi-PCR-based detection. Content Summing up C-reactin protein(CRP), procalcitonin(PCT), IL-6, lipopolysaccharides-bingding protein(LBP), soluble triggering receptor expressed on myeloid cells-1(sTREM-1), urokinase-type plasminogen activator (uPAR), high mobility group box 1 protein (HMGB1), rennin angiotensin system(RAS) and multi-PCR-based pathogen detection in early warning of sepsis. Trend Few biomarkers or bio-technologies could provide effective warning in early stage of sepsis. PCT is the most widely used method. Future researches should put more emphasis on combined use of biomarkers.

Key words: Sepsis; Biomolecular warnings; Progress